SG301-SC

· Hangzhou Sumgen Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SG301-SC, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus [Phase 1]